Vol. 5. Issue. 2. (April – June 2023)
Enfermedad pulmonar intersticial difusa
Las enfermedades pulmonares intersticiales difusas (EPID) son un grupo heterogéneo de trastornos respiratorios que habitualmente se clasifican conjuntamente ya que tienen manifestaciones clínicas, radiológicas, fisiológicas o patológicas similares. En la última década se han producido […]
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
The excellent results for monoclonal antibodies in the treatment of severe uncontrolled asthma (SUCA) represent a milestone in current treatment of asthmatic disorders. Remaining, however, are several subsidiary areas for improvement in which new biologics […]